ATE177631T1 - Synergistische malariamittel, die benflumetol enthalten - Google Patents

Synergistische malariamittel, die benflumetol enthalten

Info

Publication number
ATE177631T1
ATE177631T1 AT93902246T AT93902246T ATE177631T1 AT E177631 T1 ATE177631 T1 AT E177631T1 AT 93902246 T AT93902246 T AT 93902246T AT 93902246 T AT93902246 T AT 93902246T AT E177631 T1 ATE177631 T1 AT E177631T1
Authority
AT
Austria
Prior art keywords
benflumetol
agents containing
composition
synergistic agents
antimalarial
Prior art date
Application number
AT93902246T
Other languages
English (en)
Inventor
Anton Alexander Poltera
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE177631T1 publication Critical patent/ATE177631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93902246T 1992-02-07 1993-01-25 Synergistische malariamittel, die benflumetol enthalten ATE177631T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92810089 1992-02-07
EP92810130 1992-02-21

Publications (1)

Publication Number Publication Date
ATE177631T1 true ATE177631T1 (de) 1999-04-15

Family

ID=26132495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902246T ATE177631T1 (de) 1992-02-07 1993-01-25 Synergistische malariamittel, die benflumetol enthalten

Country Status (6)

Country Link
AT (1) ATE177631T1 (de)
DE (1) DE69323941T2 (de)
ES (1) ES2130250T3 (de)
NO (1) NO304409B1 (de)
OA (1) OA10057A (de)
RU (1) RU2118158C1 (de)

Also Published As

Publication number Publication date
NO933271L (no) 1993-09-14
ES2130250T3 (es) 1999-07-01
RU2118158C1 (ru) 1998-08-27
DE69323941T2 (de) 1999-08-26
NO933271D0 (no) 1993-09-14
OA10057A (fr) 1996-10-14
DE69323941D1 (de) 1999-04-22
NO304409B1 (no) 1998-12-14

Similar Documents

Publication Publication Date Title
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
EP0703911A1 (de) Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
PT661992E (pt) Formulacoes farmaceuticas de inibidores de interleucina-1
AR002007A1 (es) UNA COMPOSICION TERAPEUTICA DE APLICACION TOPICA QUE CONTIENE UN ANTAGONISTA DE SUSTANCIA P Y UTILIZACION DE DICHO ANTAGONISTA PARA LAPREPARACIóN DE DICHA COMPOSICION PARA DISMINUIR Y/O ELIMINAR UN EFECTO SECUNDARIO IRRITANTE DE UN PRODUCTO CONTENIDO EN LA MISMA.
LU90366I2 (fr) Nasonex
ATE245977T1 (de) Therapeutische substituierte guanidine
DK0964687T3 (da) Farmaceutiske sammensætninger med antimikrobiel aktivitet
KR960006915A (ko) 췌장염의 치료 조성물
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
KR920021143A (ko) 치매 경감제
BR9811458A (pt) "sistema solvente para penetração melhorada de compostos farmacêuticos"
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
ATE50143T1 (de) Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
KR930017885A (ko) 항종양 조성물 및 종양의 치료방법
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
ATE177631T1 (de) Synergistische malariamittel, die benflumetol enthalten
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ATE100713T1 (de) L-alpha-glycerophosphoryl-d-myoinositol zur behandlung peripherer neuropathien und cerebropathien.
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
ES2179667T3 (es) Nuevas formulaciones inyectables que contienen ramoplanina.
RU94028126A (ru) Средство, обладающее иммуномодулирующей активностью
RU94022757A (ru) Агент торможения агрегации тромбоцитов
RU94039211A (ru) Антибактериальное средство
TR200000266T2 (tr) Antimetastaz maddeler olarak faydalı oligo-tiofenler, bunların ve bunları ihtiva eden farmasötik bileşimlerin hazırlanması.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification